Literature DB >> 16709529

Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.

N Kvirikadze1, M Suseno, T Vescio, L Kaminer, K Singh.   

Abstract

The best therapeutic options for serious infections due to vancomyci resistant Enterococcus (VRE) remain unclear. We describe the successful treatment of vancomycin resistant Enterococcus faecium bacteremia in 2 patients using daptomycin. We also briefly review the literature on antibiotic options for VRE infection including the use of daptomycin.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16709529     DOI： 10.1080/00365540500434687

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  7 in total

1.  Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.

Authors:  J A McKinnell; M Patel; R M Shirley; D F Kunz; S A Moser; J W Baddley
Journal:  Epidemiol Infect       Date:  2010-11-15       Impact factor: 2.451

2.  Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.

Authors:  Debra D Poutsiaka; Serena Skiffington; Kenneth B Miller; Susan Hadley; David R Snydman
Journal:  J Infect       Date:  2006-12-26       Impact factor: 6.072

3.  Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.

Authors:  Shawna Kraft; Emily Mackler; Peter Schlickman; Kathy Welch; Daryl D DePestel
Journal:  Support Care Cancer       Date:  2010-11-26       Impact factor: 3.603

Review 4.  A potential role for daptomycin in enterococcal infections: what is the evidence?

Authors:  Rafael Cantón; Patricia Ruiz-Garbajosa; Ricardo L Chaves; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2010-04-02       Impact factor: 5.790

5.  Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient.

Authors:  Christoph Schoen; Christian Unzicker; Gernot Stuhler; Johannes Elias; Hermann Einsele; Götz Ulrich Grigoleit; Marianne Abele-Horn; Stephan Mielke
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

Review 6.  Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.

Authors:  Eleni P Balli; Chris A Venetis; Spiros Miyakis
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

Review 7.  Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.

Authors:  Yu-Chung Chuang; Jann-Tay Wang; Hsin-Yi Lin; Shan-Chwen Chang
Journal:  BMC Infect Dis       Date:  2014-12-13       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.